QUBIC x AbbVie x Eliomedica: Technology De-risking & Regulatory Strategy

Schedule

Wed Nov 25 2026 at 04:00 pm to 06:00 pm

UTC-05:00
Location

Botterell Hall | Kingston, ON

Advertisement
De-risking fundamentals, including how technical validation and regulatory planning can increase venture valuation
About this Event

Join QUBIC and Queen's Commercialization & Ventures (QCV) for an exclusive industry workshop featuring experts from AbbVie and ElioMedica.

Bringing an innovative technology from the lab to market requires more than a promising scientific discovery. Successful commercialization depends on demonstrating technical feasibility, navigating regulatory requirements, and strategically reducing development risks to build confidence among investors, industry partners, and other stakeholders.

This collaborative workshop brings together industry perspectives from ElioMedica and AbbVie to explore two critical aspects of technology commercialization: building a development roadmap that advances technology readiness and navigating the regulatory pathways for medical devices.

Through presentations and an interactive panel discussion, participants will gain practical insights into how early-stage technologies are evaluated, developed, and positioned for successful commercialization.

What You'll Learn

1. Technology Development & De-Risking | ElioMedica

  • Understanding Technology Readiness Levels (TRLs) and the progression from research to commercial application.
  • Identifying technical risks and establishing development milestones to demonstrate feasibility.
  • How validation, prototyping, and strategic evidence generation can increase technology readiness and commercial value.

2. Navigating Medical Device Regulatory Pathways | AbbVie

  • Understanding the regulatory landscape for medical devices, including key regulatory authorities and classification systems.
  • Exploring regulatory pathways and requirements for bringing medical technologies to market.
  • Identifying common regulatory challenges and the importance of integrating regulatory strategy early in product development.

3. Interactive Industry Panel & Q&A.

Following the presentations, representatives from AbbVie and ElioMedica will participate in an interactive panel discussion. Participants will have the opportunity to ask questions, explore real-world commercialization challenges, and hear industry perspectives on translating innovative technologies into viable products.


Event Details

Date: Wednesday, November 25, 2026

Time: 4:00–6:00 PM ET

Location: Botterell Hall, Room B150, Queen's University

Format: Hybrid (in-person and virtual participation)

Who Should Attend: Students, graduate researchers, aspiring entrepreneurs, and anyone interested in biotechnology, medical devices, technology development, or life sciences commercialization. Pizza and networking opportunities will be available toward the end of the event.

Hosted by QUBIC and QCV, featuring industry experts from AbbVie and ElioMedica.

Please note: Photographs may be taken during this event for promotional and social media purposes.

Advertisement

Where is it happening?

Botterell Hall, 18 Stuart Street, Kingston, Canada

Event Location & Nearby Stays:

Tickets

CAD 0.00

Know what’s Happening Next — before everyone else does.
QUBIC
Host or PublisherQUBIC

Ask AI if this event suits you